Medical pot activists fear epilepsy drug could undercut them
COLUMBUS, Ohio - An experimental epilepsy drug made from cannabis plants grown in England is complicating the medical marijuana debate in hospitals and statehouses.
Epidiolex is a nearly pure extract of cannabidiol, or CBD, with little of the tetrahydrocannabinol, or THC, that gets users high.
CBD products are the current rage in medical marijuana movement, and activists fear Food and Drug Administration approval of Epidiolex could undercut their political momentum and access to the whole plant.
Anup Patel, a pediatric neurologist at Columbus' Nationwide Children's Hospital, insists Epidiolex contains the optimal known marijuana compound for treating seizures. It will be submitted for FDA approval later this year.
So far, the FDA has not found any botanical form of marijuana to be safe or effective to treat any disease or condition.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
One transported after construction crane falls on vehicle in Henderson
DOTD to discuss widening of LA 44, roundabout in Ascension Parish
Restore Louisiana to reopen survey and extend application deadline
Doorman, veteran at local bar salutes for national anthem, becomes internet sensation
Mississippi casino revenue rises as sports betting begins